Built by people who believe the problem is solvable.

Tracey is a social impact leader with extensive experience launching and scaling global initiatives across animal welfare, climate change, and marine conservation. She has a proven track record of mobilizing large-scale capital and building high-impact collaborations with change makers, scientists, engineers, aligned philanthropies, investors, and public figures resulting in significant social impact. In animal welfare, she was the Founding CEO of Target Zero, working alongside a small group of top tier do'ers in the space to create an integrated program of Best Practices — which were mentored out to 21+ cities and counties moving them from high kill shelter rates down to zero euthanasia of all adoptable animals (in three years or less). Tracey's work has been featured in the New York Times, Forbes, Barons, The Stanford Social Innovation Review and TED, among others.

Adam is an entrepreneur and philanthropist dedicated to advancing innovative solutions to animal welfare challenges. Since 2010, Adam has served as a Director of the Amber & Adam Tarshis Foundation which supports scientific research, animal welfare initiatives, and the development of sustainable alternatives to animal-derived foods. A central focus of his philanthropic work is addressing animal overpopulation and the suffering that comes with it through scientific innovation. Recognizing the limitations of traditional surgical sterilization programs, Adam turned the Foundation's attention and funding  towards developing safe, effective, affordable, and scalable nonsurgical fertility-control technologies for companion animals and wildlife. He is also the Founder and CEO of Mozza Foods, a Los Angeles biotechnology company developing animal-free dairy proteins through molecular farming.

Dr. Mohammed Selman is an accomplished molecular biologist and virologist with extensive experience in vaccine development, viral vector technologies, gene therapy, and preclinical research. His work spans academic research and the biotechnology and pharmaceutical industries, with a focus on translating scientific discoveries into potential therapeutic applications. Dr. Selman currently serves as a Scientist II at Meissa Vaccines, where he supports the development and characterization of live-attenuated vaccines for emerging and respiratory infectious diseases. Previously, he was a Senior Scientist at Merck Research Laboratories, contributing to the development of oncolytic virotherapies, gene delivery technologies, and CRISPR-based research. His work included collaborations across biologics, manufacturing, infectious disease, and animal health teams. Earlier in his career, Dr. Selman conducted research at the University of Southern California's Keck School of Medicine, the Ottawa Hospital Research Institute, Princeton University, Kyoto University, and McGill University. His expertise encompasses viral engineering, immunology, molecular biology, vaccine development, and the design and execution of preclinical studies.

Dr. Mike Greenberg is a veterinarian who has dedicated his career to expanding access to veterinary care. He performs high-quality, high-volume spay/neuter in shelters and accessible-care clinics across the Gulf South, and he co-founded Be Spay-Neuter Consulting, which helps spay/neuter clinics and shelters improve surgical access, efficiency, and quality of care through data-informed workflow optimization. Dr. Greenberg earned his DVM from Cornell University's College of Veterinary Medicine, followed by an internship and fellowship in shelter medicine through Cornell's Maddie's Shelter Medicine Program, where he co-authored Every Nose Counts, a book on using data in animal shelters. He went on to serve as Program Director of Target Zero and Director of Outreach Programs at Maddie's Fund. Though he enjoys surgery, non-surgical sterilization has been a passion of his since he first encountered the idea in veterinary school. He has championed the concept ever since, working with the Alliance for Contraception in Cats and Dogs and other stakeholders, and he looks forward to the day when sterilizing an animal no longer requires opening a scalpel blade. Dr. Greenberg also works at the intersection of animal welfare and technology. He co-founded the Veterinary Care Accessibility Project, a nonprofit building data-driven tools to map and close gaps in veterinary care access, and Petszel, a post-adoption support platform used by shelters nationwide. He makes his home in New Orleans, Louisiana.